N. Riegman
Impact in
- Endocrinology top 5%
- Escherichia coli research studies
Papers in
-
- RNA and protein synthesis mechanisms 3
- Lipid Membrane Structure and Behavior 1
- Genetics 5
- Bacterial Genetics and Biotechnology 4
- Co-authors
- J. J. M. Meulenberg (2 shared papers)Erica Sellink (2 shared papers)P.W. Postma (2 shared papers)Hans Bergmans (8 shared papers)Irma van Die (6 shared papers)W. P. M. Hoekstra (8 shared papers)Ron Kusters (1 shared paper)Paul M.P. van Bergen en Henegouwen (1 shared paper)
- Journals
- Molecular Microbiology (4 papers)Journal of Bacteriology (2 papers)The EMBO Journal (1 paper)European Journal of Biochemistry (1 paper)FEMS Microbiology Letters (3 papers)
- Partner nations
- NetherlandsFinland
In The Last Decade
N. Riegman
12 papers receiving 347 citations
Peers
Comparison fields: 5 of 57
- Endocrinology 113
- Molecular Medicine 25
- Biochemistry 31
- Microbiology 22
- Molecular Biology 233
Countries citing papers authored by N. Riegman
This map shows the geographic impact of N. Riegman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Riegman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Riegman more than expected).
Fields of papers citing papers by N. Riegman
This network shows the impact of papers produced by N. Riegman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Riegman. The network helps show where N. Riegman may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Riegman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 110 | |
| 2 | 1990 | 49 | |
| 3 | 1991 | 42 | |
| 4 | 1990 | 32 | |
| 5 | 1988 | 28 | |
| 6 | 1988 | 25 | |
| 7 | 1990 | 17 | |
| 8 | 1988 | 16 | |
| 9 | 1984 | 14 | |
| 10 | 1986 | 13 | |
| 11 | 1988 | 12 | |
| 12 | 1990 | 3 |
About N. Riegman
N. Riegman is a scholar working on Molecular Biology, Genetics, Endocrinology, Radiology, Nuclear Medicine and Imaging and Materials Chemistry, having authored 12 papers that have together received 361 indexed citations. Recurring topics across this work include Escherichia coli research studies (5 papers), Bacterial Genetics and Biotechnology (4 papers), RNA and protein synthesis mechanisms (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Enzyme Structure and Function (2 papers), Animal Disease Management and Epidemiology (1 paper), Lipid Membrane Structure and Behavior (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Endocrinology (113 citations), Molecular Medicine (25 citations), Biochemistry (31 citations), Microbiology (22 citations) and Molecular Biology (233 citations). N. Riegman has collaborated with scholars based in Netherlands and Finland. Frequent co-authors include J. J. M. Meulenberg, Erica Sellink, P.W. Postma, Hans Bergmans, Irma van Die, W. P. M. Hoekstra, Ron Kusters, Paul M.P. van Bergen en Henegouwen, Jörg Hacker and Jan L. M. Leunissen. Their work appears in journals such as Molecular Microbiology, Journal of Bacteriology, The EMBO Journal, European Journal of Biochemistry and FEMS Microbiology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.